ARS Pharmaceuticals (SPRY) Stock Chart & Stock Price History $16.70 +0.61 (+3.79%) Closing price 03:59 PM EasternExtended Trading$16.73 +0.03 (+0.15%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ARS Pharmaceuticals Stock Price Performance The ARS Pharmaceuticals (SPRY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 92.84%, with a year-to-date return of 58.29%. In the past month, the stock has increased 15.49%, reflecting recent market activity. As of the latest close, ARS Pharmaceuticals traded at $16.09 with a market cap of $1.58 billion and volume of 1.86 million shares. Receive SPRY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.24%1 Month Performance+15.49%3 Month Performance+27.97%Year-To-Date Performance+58.29%1 Year Performance+92.84% SPRY Stock Chart for Wednesday, July, 2, 2025 SPRY Chart by TradingView ARS Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$17.45$16.09-7.79%$17.41$16.001.86 million shs$1.58 billion06/30/2025$18.20$17.45-4.12%$18.50$16.163.16 million shs$1.71 billion06/27/2025$18.08$18.20+0.66%$18.90$18.113.88 million shs$1.79 billion06/26/2025$17.26$18.08+4.75%$18.21$17.271.80 million shs$1.78 billion06/25/2025$16.78$17.26+2.86%$17.54$16.851.40 million shs$1.70 billion06/24/2025$16.57$16.78+1.27%$17.50$16.301.94 million shs$1.65 billion06/23/2025$15.80$16.57+4.87%$16.59$15.671.41 million shs$1.63 billion06/20/2025$15.91$15.80-0.69%$16.11$15.451.34 million shs$1.55 billion06/19/2025$15.91$15.91$16.23$14.802.73 million shs$1.56 billion06/18/2025$14.82$15.91+7.35%$16.23$14.802.73 million shs$1.56 billion Get the Latest News and Ratings for SPRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$15.16$14.82-2.24%$15.12$14.77983,659 shs$1.46 billion06/16/2025$15.39$15.16-1.49%$15.68$14.861.44 million shs$1.49 billion06/13/2025$14.40$15.39+6.88%$15.43$14.151.17 million shs$1.51 billion06/12/2025$14.34$14.40+0.42%$14.51$14.10588,579 shs$1.41 billion06/11/2025$14.69$14.34-2.38%$14.80$14.30559,030 shs$1.41 billion06/10/2025$14.53$14.69+1.10%$14.78$14.36544,988 shs$1.44 billion06/09/2025$14.49$14.53+0.28%$14.87$14.211.07 million shs$1.43 billion06/06/2025$13.44$14.49+7.81%$14.54$13.541.27 million shs$1.42 billion06/05/2025$13.82$13.44-2.75%$13.85$13.281.24 million shs$1.32 billion06/04/2025$14.53$13.82-4.89%$14.70$13.79847,793 shs$1.36 billion06/03/2025$14.46$14.53+0.48%$14.87$14.201.16 million shs$1.43 billion06/02/2025$14.68$14.46-1.50%$14.79$14.04982,162 shs$1.42 billion Related Companies LEGN Stock Chart TGTX Stock Chart GRFS Stock Chart LNTH Stock Chart TLX Stock Chart NUVL Stock Chart AXSM Stock Chart AKRO Stock Chart PCVX Stock Chart ADMA Stock Chart Receive SPRY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ARS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SPRY) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPRY Stock Alerts